ORMP icon

Oramed Pharmaceuticals

56 hedge funds and large institutions have $5.99M invested in Oramed Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding:

more ownership

Funds ownership:

8% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 13

27% less capital invested

Capital invested by funds: $8.15M → $5.99M (-$2.16M)

Holders
56
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$158K
Puts
$75K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$2.04M
2
$756K
3
$432K
4
$401K
5
$232K
6
$232K
7
$158K
8
$148K
9
$138K
10
$120K
11
$116K
12
$108K
13
$97.1K
14
$82.3K
15
$71.2K
16
$70.9K
17
$54.6K
18
$53.6K
19
$51.4K
20
$49K
21
$47K
22
$45K
23
$38K
24
$34.1K
25
$33.8K